Angstrom Medica bought by Mich. firm

October 31, 2007 on 8:17 pm | In Uncategorized | Comments Off
Angstrom Medica Inc., a Woburn startup focused on nanomaterials to rebuild human bones, has been acquired by a Michigan company, according to the buyer.

ZymoGenetics beats Q3 expectations

October 31, 2007 on 5:47 pm | In Uncategorized | Comments Off
ZymoGenetics Inc. reported a third-quarter net loss of $39 million, or a loss of 57 cents per share, which compares with a loss of $31.2 million, or a loss of 47 cents a share a year earlier. (ZGEN)

EMD Serono has new CEO

October 31, 2007 on 5:46 pm | In Uncategorized | Comments Off
EMD Serono Inc. has appointed Fereydoun Firouz as chief executive officer and president.

NTI gets $2.1 million royalty payment

October 31, 2007 on 5:24 pm | In Uncategorized | Comments Off Neurobiological Technologies Inc. has received approximately $2.1 million from Merz Pharmaceuticals GmbH and its marketing partners for sales of Memantine for the treatment of Alzheimer's disease during the quarter ended June 30.

Neurobiological Technologies gets $2M royalty payment

October 31, 2007 on 4:35 pm | In Uncategorized | Comments Off Drug company Neurobiological Technologies Inc. got a $2.1 million royalty payment for sales of its Alzheimer's disease drug Memantine. (NTII)

Next Page »

Powered by WordPress with Pool theme design by Borja Fernandez.